What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Cancer
Charles N. Bernstein mostly deals with Internal medicine, Inflammatory bowel disease, Ulcerative colitis, Gastroenterology and Crohn's disease.
Charles N. Bernstein combines subjects such as Placebo and Surgery with his study of Internal medicine.
His Inflammatory bowel disease study introduces a deeper knowledge of Disease.
His Ulcerative colitis study incorporates themes from Epidemiology, Colitis, Cohort study, Case-control study and Intensive care medicine.
His Gastroenterology research is multidisciplinary, relying on both Endocrinology, Dose–response relationship and Proportional hazards model.
His work investigates the relationship between Crohn's disease and topics such as Retrospective cohort study that intersect with problems in Young adult.
His most cited work include:
- Toward an Integrated Clinical, Molecular and Serological Classification of Inflammatory Bowel Disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology (2220 citations)
- High prevalence of Escherichia coli belonging to the B2+D phylogenetic group in inflammatory bowel disease (330 citations)
- The Manitoba IBD cohort study: a population-based study of the prevalence of lifetime and 12-month anxiety and mood disorders. (270 citations)
What are the main themes of his work throughout his whole career to date?
Charles N. Bernstein mainly investigates Internal medicine, Inflammatory bowel disease, Gastroenterology, Ulcerative colitis and Disease.
Internal medicine is closely attributed to Surgery in his work.
His study in Inflammatory bowel disease is interdisciplinary in nature, drawing from both Colitis, Immunology, Epidemiology, Intensive care medicine and Physical therapy.
Gastroenterology is closely attributed to Colonoscopy in his research.
His research links Infliximab with Ulcerative colitis.
His work carried out in the field of Disease brings together such families of science as Health care and MEDLINE.
He most often published in these fields:
- Internal medicine (44.89%)
- Inflammatory bowel disease (38.28%)
- Gastroenterology (22.07%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (44.89%)
- Inflammatory bowel disease (38.28%)
- Disease (19.83%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Internal medicine, Inflammatory bowel disease, Disease, Ulcerative colitis and Crohn's disease.
Charles N. Bernstein has researched Internal medicine in several fields, including Gastroenterology, Depression and Anxiety.
His research integrates issues of Tumor necrosis factor alpha, Health care, Incidence, Intensive care medicine and Endoscopy in his study of Inflammatory bowel disease.
In Disease, Charles N. Bernstein works on issues like Gluten, which are connected to Newly diagnosed.
His Ulcerative colitis study which covers Infliximab that intersects with Adalimumab.
His Crohn's disease research includes themes of First-degree relatives, Immunology and MEDLINE.
Between 2018 and 2021, his most popular works were:
- Management of Patients With Crohn's Disease and Ulcerative Colitis During the Coronavirus Disease-2019 Pandemic: Results of an International Meeting. (94 citations)
- Past and Future Burden of Inflammatory Bowel Diseases Based on Modeling of Population-Based Data. (83 citations)
- Introduction of anti-TNF therapy has not yielded expected declines in hospitalisation and intestinal resection rates in inflammatory bowel diseases: a population-based interrupted time series study (55 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Cancer
The scientist’s investigation covers issues in Disease, Inflammatory bowel disease, Internal medicine, Ulcerative colitis and Crohn's disease.
His research in Disease intersects with topics in Gut flora, Immunology, Epidemiology, Quality of life and Intensive care medicine.
His Inflammatory bowel disease study combines topics from a wide range of disciplines, such as General surgery, Health care, Endoscopy and MEDLINE.
The various areas that he examines in his Internal medicine study include Gastroenterology, Depression and Gluten.
The concepts of his Ulcerative colitis study are interwoven with issues in Confirmatory factor analysis, Primary sclerosing cholangitis, Colitis and Combination therapy.
His study focuses on the intersection of Crohn's disease and fields such as Infliximab with connections in the field of Colectomies, Interrupted time series and Randomized controlled trial.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
